MDxHealth, Ghent form pharmacoepigenomics center, 2/13:112

Create PDF

MDxHealth has joined forces with Ghent University to establish NXTGNT, a pharmacoepigenomics center.

The center’s mission is to accelerate innovation in personalized medicine by using advanced technology, knowledge, and expertise in epigenetics. The center will bring together scientific expertise from disease-centered basic researchers, corresponding clinical validation teams, bioinformaticians, and epigenomic technology focused on the discovery of effective individualized epigenetic-based diagnostic and personalized therapeutic products.